Tag
- Pfizer's paxlovid reduces the risk of COVID-19 by 26% 2022-11-07
- The battle between Pfizer and Gilead over COVID-19 drugs wil... 2022-11-03
- 1200 cases were newly prescribed by Junshi Biologic for mild... 2022-10-24
- Twenty-five COVID-19 Vaccines In China Enter Stages Of Clini... 2022-06-09
- Pfizer to Increase Production Capacity of COVID-19 Oral Drug... 2022-06-08
- Anke Bio and Afana Collaborate on mRNA Vaccines for Mutant S... 2022-05-17
- As Low as $25/session! Pfizer's COVID-19 Oral Drug Paxlovid ... 2022-05-16
- Survey On Corona Deaths By Country 2022-05-09
- COVID-19 Drug Remdesivir Approved for Infants And Young Chil... 2022-04-28
- Roche's Q1 Performance Increases by 10%, And Total Revenue f... 2022-04-26
Market Analysis
- Insufficient Downstream Demand Puts Pressure on DMF Market Dec-18,2025
- After Two Rounds of Price Cuts, the Coke Market Stabilizes in China Dec-18,2025
- Cyclohexane Market Supply and Demand Balance, Prices Remain Stable Dec-18,2025
- Methanol Market Partially Rises Dec-18,2025
- Raw Material Support Drives Uptick in Adipic Acid Prices Dec-17,2025